We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+6%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.6B
AUM Growth
+$1.02B
(+7.5%)
Cap. Flow
+$301M
Cap. Flow
% of AUM
2.05%
Top 10 Holdings %
Top 10 Hldgs %
11.52%
Holding
3,073
New
178
Increased
750
Reduced
784
Closed
271
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$75.2M |
| 2 |
Biogen
BIIB
|
+$65.9M |
| 3 |
Illinois Tool Works
ITW
|
+$49.7M |
| 4 |
CVS Health
CVS
|
+$46.7M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$43.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$51.1M |
| 2 |
Microsoft
MSFT
|
+$48.7M |
| 3 |
eBay
EBAY
|
+$42.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$40.6M |
| 5 |
Lockheed Martin
LMT
|
+$38.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.66% |
| 2 | Healthcare | 15.18% |
| 3 | Financials | 11.75% |
| 4 | Industrials | 10.75% |
| 5 | Consumer Discretionary | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Principal Financial Group
PFG
$23.6B
| $10.9M | 0.07% |
243,288
-71,538
| -23% | -$3.49M |
|
327
Delek US
DK
$3.87B
| $10.9M | 0.07% |
444,430
+427,551
| +2,533% | +$11.2M |
|
328
International Flavors & Fragrances
IFF
$19.4B
| $10.7M | 0.07% |
89,446
-1,637
| -2% | -$189K |
|
329
Analog Devices
ADI
$181B
| $10.6M | 0.07% |
192,241
-2,035
| -1% | -$120K |
|
330
Invesco FTSE RAFI US 1000 ETF
PRF
$9.73B
| $10.5M | 0.07% |
601,905
-39,585
| -6% | -$698K |
|
331
Broadridge
BR
$17.2B
| $10.4M | 0.07% |
194,020
+188,186
| +3,226% | +$10.6M |
|
332
Norfolk Southern
NSC
$78.8B
| $10.4M | 0.07% |
122,918
-1,129
| -0.9% | -$96.6K |
|
333
Genuine Parts
GPC
$17.1B
| $10.3M | 0.07% |
120,055
-1,406
| -1% | -$123K |
|
334
Adobe
ADBE
$89.5B
| $10.1M | 0.07% |
107,169
-8,188
| -7% | -$736K |
|
335
IQVIA
IQV
$34.7B
| $10M | 0.07% |
145,795
+58,427
| +67% | +$3.99M |
|
336
TE Connectivity
TEL
$58.8B
| $9.98M | 0.07% |
154,532
-35,122
| -19% | -$2.26M |
|
|
SPLS
337
DELISTED
Staples Inc
SPLS
| $9.98M | 0.07% |
1,053,688
-581
| -0.1% | -$6.82K |
|
338
Hershey
HSY
$35.4B
| $9.87M | 0.07% |
110,567
-1,683
| -1% | -$151K |
|
339
RenaissanceRe
RNR
$13.7B
| $9.63M | 0.07% |
85,058
| – | – |
|
340
Teva Pharmaceuticals
TEVA
$35.9B
| $9.51M | 0.06% |
144,972
+26,660
| +23% | +$1.65M |
|
341
Quest Diagnostics
DGX
$25.1B
| $9.39M | 0.06% |
131,994
-1,368
| -1% | -$92K |
|
342
Corning
GLW
$126B
| $9.08M | 0.06% |
496,721
-2,236
| -0.4% | -$40.5K |
|
343
Advance Auto Parts
AAP
$3.37B
| $9.06M | 0.06% |
60,181
-3,261
| -5% | -$566K |
|
344
Clorox
CLX
$11.6B
| $8.71M | 0.06% |
68,654
+556
| +0.8% | +$69K |
|
345
Berkshire Hathaway Class A
BRK.A
$1.07T
| $8.7M | 0.06% |
44
+7
| +19% | +$1.41M |
|
346
Lamar Advertising Co
LAMR
$16.2B
| $8.62M | 0.06% |
143,672
-505
| -0.4% | -$29K |
|
|
PCP
347
DELISTED
PRECISION CASTPARTS CORP
PCP
| $8.53M | 0.06% |
36,779
-3,873
| -10% | -$895K |
|
348
iShares MSCI Emerging Markets ETF
EEM
$28B
| $8.42M | 0.06% |
261,555
-298,547
| -53% | -$10.2M |
|
349
Truist Financial
TFC
$63.2B
| $8.41M | 0.06% |
222,511
+193,506
| +667% | +$7.28M |
|
350
Coca-Cola Europacific Partners
CCEP
$46.5B
| $8.35M | 0.06% |
169,579
-1,883
| -1% | -$94.8K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q4 2015 Portfolio in Review
As of Q4 2015, Glenmede Trust held 3,073 positions worth $14.6B, up 7.5% from $13.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Glenmede Trust's Q4 2015 filing shows 178 new, 750 increased, 784 reduced and 271 closed positions. Its largest new stake was Alphabet (Google) Class A: 1,170,400 shares worth $45.5M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $51.1M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Glenmede Trust's largest Q4 2015 buy was Alphabet (Google) Class A: 1,170,400 shares worth $45.5M.
- Glenmede Trust added most to VMware, Inc in Q4 2015, an estimated $75.2M increase.
- Glenmede Trust's biggest Q4 2015 reduction was Microsoft, cutting an estimated $48.7M.
- Glenmede Trust fully exited Vanguard FTSE Developed Markets ETF in Q4 2015, selling an estimated $51.1M.
- Glenmede Trust's ten largest holdings make up 12% of its $14.6B portfolio in Q4 2015.
- Glenmede Trust opened 178 new positions and closed 271 in Q4 2015.
- Glenmede Trust's portfolio value rose 7.5% quarter-over-quarter to $14.6B.
Based on Glenmede Trust's 13F filing for Q4 2015, filed 11 Feb 2016.